About Us  Contact Information - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

About Us

PharmTech.com is a comprehensive information source for all professionals in the global pharmaceutical manufacturing drug development community, brought to you by Pharmaceutical Technology and Pharmaceutical Technology Europe.

We provide professionals with dynamic and reliable cutting-edge peer-reviewed content and features on next-generation process development and manufacturing, formulation, drug delivery, ingredients, regulation, analytics, packaging, supply-chain, and outsourcing. We also provide comprehensive coverage of international regulations and business trends relating to drug development.

PharmTech.com is part of the Life Sciences unit of Advanstar Communications that serves the healthcare, dental and veterinary fields, as well as pharmaceutical, science and drug discovery markets. View our LifeScience offerings.

Editorial Mission:

Pharmaceutical Technology is the authoritative source of peer-reviewed research and expert analyses for scientists, engineers, and managers engaged in process development, manufacturing, formulation and drug delivery, API synthesis, analytical technology and testing, packaging, IT, outsourcing, and regulatory compliance in the pharmaceutical and biotechnology industries.

Pharmaceutical Technology Europe (PTE) reports on developments in European pharmaceutical/biopharmaceutical development, manufacturing, and quality assurance and control. Providing technically focused peer-reviewed editorial, opinion, trends and analysis, PTE assists readers in their decision-making and implementation of best practice.


Further Information

Editorial Advisory Board

Author Guidelines

Subscribe

Advertise

Rent Mail Lists

Purchase Reprints

Download Media Kits


Contacts

Editorial

Sales

To report technical issues or to offer feedback to improve the site, please contact the Webmaster.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
38%
Breakthrough designations
13%
Protecting the supply chain
38%
Expedited reviews of drug submissions
13%
More stakeholder involvement
0%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here